Pediatric Oncology Group of Ontario
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer
Role: collaborator
Improving Quality and Consistency in Family Education Prior to First Discharge Following Pediatric Cancer Diagnosis
Role: collaborator
N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors
Role: collaborator
Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
Role: collaborator
Preventing Cardiac Sequelae in Pediatric Cancer Survivors
Role: collaborator
Outpatient Yoga Study for Adolescents Receiving Chemotherapy
Role: collaborator
Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)
Role: collaborator
All 7 trials loaded